Clinical Trials in Texas

Showing 8101-8120 of 15,101 trials

Can Virtual Reality Reduce Pain and Anxiety During Blood Draw

NCT04449341

Adult patients aged 18-50 undergoing blood draw for routine lab evaluation will be randomized to a control group or experimental group to assess if the use of virtual reality reduces procedural pain (primary outcome) and procedural anxiety (secondary outcome) during venipuncture.

Procedural AnxietyProcedural Pain

C.R.Darnall Army Medical Center59 participantsStarted Jun 2020

Fort Hood, Texas, United States

COMPLETEDPhase 255 miles

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

NCT02798406

Glioblastoma (GBM) and gliosarcoma (GS) are the most common and aggressive forms of malignant brain tumor in adults and can be resistant to conventional therapies. The purpose of this Phase II study is to evaluate how well a recurrent glioblastoma or gliosarcoma tumor responds to one injection of DNX-2401, a genetically modified oncolytic adenovirus, when delivered directly into the tumor followed by the administration of intravenous pembrolizumab (an immune checkpoint inhibitor) given every 3 weeks for up to 2 years or until disease progression. Funding Source-FDA OOPD

Brain CancerBrain NeoplasmGlioma+8 more

DNAtrix, Inc.49 participantsStarted Oct 2016

Little Rock, Arkansas, United States • Los Angeles, California, United States • Chicago, Illinois, United States +12 more locations

Can Virtual Reality Reduce Pain and Anxiety During Blood Draw

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

Find Trials by Condition in Texas

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects

A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements

Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee

Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

Trial of Extended Release Bupivacaine for Pain Relief After Surgery

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Healthy Term Infants Fed Milk-Based Infant Formula

Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves

Alglucosidase Alfa Pompe Safety Sub-Registry